ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

Analysts Cut Homebuilders, Lift Pharma

By ORTEX News · Edited by , Editor, ORTEX News1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Analysts trimmed price targets on LEN this week. The consensus target fell to $89.50 from $90.14. Lennar carries short interest at 8.76% of free float. That elevated short position signals the market is already cautious on the homebuilder.

GIS also drew a target cut. Analysts lowered the average to $37.00 from $37.56. General Mills has posted a rough stretch. Short interest sits near 9.3% of free float. Analysts appear to see little near-term catalyst for recovery.

On the other side, GILD got a lift. The consensus target moved up to $157.57 from $157.04. Gilead carries a $155 billion market cap. Short interest is just 2.1% of free float — bears are not betting against this one.

SCHW also attracted positive target revisions. Charles Schwab's average target rose to $116.05 from $115.85. The upgrade trend in financials mirrors broader optimism around rate normalization.

DRI bucked the consumer discretionary gloom. Analysts nudged Darden Restaurants' target higher to $226.23. Restaurant spending data appears to be holding up better than feared.

The clearest pattern: analysts are cutting consumer staples and housing while lifting healthcare and financials.

Stocks in this article

How this article was generated

Generated
13 Jun 2026, 16:20
Prompt version
v1.0
Data sources
Analyst consensus

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.